These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 34102154)

  • 21. Long-term outcomes of Boston keratoprosthesis type I: the Chinese People's Liberation Army General Hospital experience.
    Wang LQ; Wu TY; Chen XN; Xu ZQ; Yang M; Xiang R; Ma X; Zhang S; Huang YF
    Br J Ophthalmol; 2022 Jun; 106(6):781-785. PubMed ID: 33674425
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long-term visual outcomes of the Boston type I keratoprosthesis in Canada.
    Szigiato AA; Bostan C; Nayman T; Harissi-Dagher M
    Br J Ophthalmol; 2020 Nov; 104(11):1601-1607. PubMed ID: 32066560
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Long-term visual outcomes of Boston type I keratoprosthesis in Canada].
    Aoun T; Harissi-Dagher M
    J Fr Ophtalmol; 2023 Dec; 46(10):1212-1221. PubMed ID: 37867123
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Type 1 Boston keratoprosthesis: outcomes at two Canadian centres.
    Noel CW; Isenberg J; Goldich Y; Conlon R; Teichman J; Rubinger DA; Weinberg TA; Slomovic J; Chan CC; Rootman DS; Baig KM; Slomovic AR
    Can J Ophthalmol; 2016 Apr; 51(2):76-82. PubMed ID: 27085262
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Boston type I keratoprosthesis: improving outcomes and expanding indications.
    Aldave AJ; Kamal KM; Vo RC; Yu F
    Ophthalmology; 2009 Apr; 116(4):640-51. PubMed ID: 19243830
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Microbial Keratitis and Endophthalmitis After the Boston Type 1 Keratoprosthesis.
    Wagoner MD; Welder JD; Goins KM; Greiner MA
    Cornea; 2016 Apr; 35(4):486-93. PubMed ID: 26764885
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Outcomes of the Boston Type I Keratoprosthesis as the Primary Penetrating Corneal Procedure.
    Driver TH; Aravena C; Duong HNV; Christenbury JG; Yu F; Basak SK; Aldave AJ
    Cornea; 2018 Nov; 37(11):1400-1407. PubMed ID: 30157053
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Boston Keratoprosthesis in severe ocular trauma.
    Harissi-Dagher M; Dohlman CH
    Can J Ophthalmol; 2008 Apr; 43(2):165-9. PubMed ID: 18347618
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Long-Term Outcomes of the Boston Type I Keratoprosthesis in the Management of Corneal Limbal Stem Cell Deficiency.
    Aravena C; Bozkurt TK; Yu F; Aldave AJ
    Cornea; 2016 Sep; 35(9):1156-64. PubMed ID: 27387566
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Boston type 1 keratoprosthesis: the CHUM experience.
    Robert MC; Harissi-Dagher M
    Can J Ophthalmol; 2011 Apr; 46(2):164-8. PubMed ID: 21708085
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Boston Keratoprosthesis Outcomes in Severe Ocular Chemical Burns in Southern China: A Retrospective Study.
    Gu J; Zhai J; Zhou S; Chen J
    Adv Ther; 2016 May; 33(5):760-73. PubMed ID: 27126407
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Boston keratoprosthesis in the management of corneal limbal stem cell deficiency.
    Sejpal K; Yu F; Aldave AJ
    Cornea; 2011 Nov; 30(11):1187-94. PubMed ID: 21885964
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Glaucoma Risk Factors and Outcomes Following Boston Keratoprosthesis Type 1 Surgery.
    Geoffrion D; Harissi-Dagher M
    Am J Ophthalmol; 2021 Jun; 226():56-67. PubMed ID: 33493469
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Endophthalmitis in Eyes With the Boston Type I Keratoprosthesis: Incidence, Recurrence, Risk Factors, and Outcomes.
    Bostan C; Nayman T; Szigiato AA; Morfeq H; Harissi-Dagher M
    Cornea; 2021 Oct; 40(10):1258-1266. PubMed ID: 33394754
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Assessment of the Role and Timing of Glaucoma Surgery in Boston Keratoprosthesis Type 1 Patients.
    Geoffrion D; Hassanaly SI; Marchand M; Daoud R; Agoumi Y; Harissi-Dagher M
    Am J Ophthalmol; 2022 Mar; 235():249-257. PubMed ID: 34543660
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Boston keratoprosthesis outcomes and complications.
    Chew HF; Ayres BD; Hammersmith KM; Rapuano CJ; Laibson PR; Myers JS; Jin YP; Cohen EJ
    Cornea; 2009 Oct; 28(9):989-96. PubMed ID: 19724214
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Infectious Keratitis After Boston Type 1 Keratoprosthesis Implantation.
    Ghaffari R; Bonnet C; Yung M; Bostan C; Harissi-Dagher M; Aldave AJ
    Cornea; 2021 Oct; 40(10):1298-1308. PubMed ID: 33630813
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Boston keratoprosthesis in Stevens-Johnson syndrome.
    Sayegh RR; Ang LP; Foster CS; Dohlman CH
    Am J Ophthalmol; 2008 Mar; 145(3):438-44. PubMed ID: 18207122
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Primary implantation of type I Boston keratoprosthesis in nonautoimmune corneal diseases.
    Chang HY; Luo ZK; Chodosh J; Dohlman CH; Colby KA
    Cornea; 2015 Mar; 34(3):264-70. PubMed ID: 25611395
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Boston keratoprosthesis: 73 eyes from Germany : An overview of experiences from two centers].
    Schaub F; Neuhann I; Enders P; Bachmann BO; Koller B; Neuhann T; Cursiefen C
    Ophthalmologe; 2018 Sep; 115(9):744-753. PubMed ID: 29043440
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.